SURROZEN
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with potential application across multiple disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas and central nervous system.
SURROZEN
Social Links:
Industry:
Biotechnology Emergency Medicine Health Care
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.surrozen.com
Total Employee:
11+
Status:
Active
Total Funding:
270.5 M USD
Technology used in webpage:
IPv6 COVID-19 Digital Ocean Akamai Hosted
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
ESCAPE Bio
ESCAPE Bio is a clinical-stage biopharmaceutical company that develops small molecule drugs intended to treat neurodegenerative diseases.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Human Life CORD
Human Life Cord specializes in regenerative medicine.
Paragon Genomics, Inc.
provide high-quality target enrichment solutions to the genomics community to advance precision medicine and research
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Resolve to Save Lives
Resolve to Save Lives is a global health initiative that aims to save millions of lives from cardiovascular disease.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - Surrozen
The Column Group
The Column Group investment in Post-IPO Equity - Surrozen
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Surrozen
Stonepine Capital Management
Stonepine Capital Management investment in Post-IPO Equity - Surrozen
StemPoint Capital
StemPoint Capital investment in Post-IPO Equity - Surrozen
The Column Group
The Column Group investment in Post-IPO Equity - Surrozen
Consonance Capital Partners
Consonance Capital Partners investment in Post-IPO Equity - Surrozen
Euclidean Capital
Euclidean Capital investment in Series C - Surrozen
Horizons Ventures
Horizons Ventures investment in Series C - Surrozen
The Column Group
The Column Group investment in Series C - Surrozen
Official Site Inspections
http://www.surrozen.com Semrush global rank: 5.97 M Semrush visits lastest month: 1.17 K
- Host name: a20b9ee60132ef283.awsglobalaccelerator.com
- IP address: 76.223.27.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Surrozen"
About Us - Surrozen
Surrozen is pioneering a new class of targeted regenerative antibodies to repair a broad range of tissues and restore organs damaged by serious disease. By designing tissue-specific …See details»
Surrozen - Crunchbase Company Profile & Funding
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing …See details»
Surrozen, Inc. - AnnualReports.com
Surrozen is a clinical stage biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body’s existing biological …See details»
Surrozen, Inc. (SRZN) Company Profile & Facts - Yahoo Finance
See the company profile for Surrozen, Inc. (SRZN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Investors | Surrozen
Nov 4, 2024 Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Wnt signaling plays key roles in the control of …See details»
Surrozen Company Profile - Office Locations, Competitors ... - Craft
Surrozen has 3 employees at their 1 location and $12.5 m in annual revenue in FY 2022. See insights on Surrozen including office locations, competitors, revenue, financials, executives, …See details»
Surrozen - The Org
Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through …See details»
Surrozen, Inc. (SRZN) Company Profile & Overview - Stock Analysis
Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody …See details»
Surrozen - Funding, Financials, Valuation & Investors - Crunchbase
Surrozen is registered under the ticker NASDAQ:SRZN . Surrozen is funded by 10 investors. Nantahala Capital Management and The Column Group are the most recent investors. …See details»
Surrozen - Overview, News & Similar companies | ZoomInfo.com
Who is Surrozen. Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tiss ue-specific …See details»
Surrozen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Surrozen is a clinical stage biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies …See details»
Overview - Surrozen
At Surrozen, we are pioneering a new class of targeted regenerative antibodies to repair a broad range of tissues and restore organs damaged by serious disease. Our vision is to engage the …See details»
Surrozen - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Surrozen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Surrozen has 2 board members and …See details»
Surrozen Company Profile Funding & Investors | YourStory
Surrozen Inc. is a biotechnology company pioneering a new class of targeted regenerative antibodies. HealthTech / MedTech / Healthcare , BioTech/BioPharmaceutical Claim ProfileSee details»
Surrozen Debuts as Publicly Traded Leader in Wnt Biology and …
Aug 11, 2021 Surrozen Contact Information 171 Oyster Point Blvd., Suite 400 South San Francisco, CA 94080 Tel.: (650) 475-2820 Email: [email protected]. Media Contact Surabhi …See details»
Surrozen Announces Strategic Partnership with Boehringer …
Oct 6, 2022 The collaboration and licensing agreement is Surrozen’s first strategic partnership for one of its compounds in development Surrozen's novel antibody-based approach targets …See details»
Surrozen Appoints Charles Williams as Chief Financial Officer
About Surrozen’s Proprietary Antibody Platforms and Harnessing Wnt Signaling Since its founding in 2016, Surrozen has developed two proprietary platforms to selectively modulate the Wnt …See details»
Surrozen
Surrozen’s technology platforms render this pathway accessible to drug discovery in an unprecedented manner, paving the way for a new class of regenerative medicines,” said Mr. …See details»
Guselkumab in patients with moderately to severely active …
4 days ago The primary populations of these two phase 3, randomised, double-blind, placebo-controlled studies (QUASAR phase 3 induction and maintenance) included randomised and …See details»
Form SCHEDULE 13G for Surrozen Incde filed 11/14/2024
SURROZEN, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 86889P208 (CUSIP Number) 09/30/2024 (Date of Event Which Requires Filing …See details»